Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Analyzing a consumer beverage company's SEC filings reveals how well its products perform at retail and whether brand investments translate to profitable growth. For Vita Coco Company (NASDAQ: COCO), the coconut water market leader, these documents show performance across retail channels and geographic regions.
Vita Coco's 10-K annual reports break down revenue by product category and distribution channel, showing how the flagship coconut water brand performs alongside newer product extensions. These filings also detail gross margins, which indicate pricing power and manufacturing efficiency in a competitive beverage market where private label alternatives exist.
The company's 10-Q quarterly filings track seasonal patterns in beverage consumption and reveal how promotional activity affects profitability. Consumer packaged goods companies like Vita Coco often show meaningful quarter-to-quarter variation based on retailer programs and marketing spend timing.
Form 4 insider transactions show when executives and directors buy or sell COCO shares. For a company that went public relatively recently, insider activity can signal management confidence in the growth trajectory. Our platform tracks these filings automatically so you can monitor executive transactions without manually searching EDGAR.
8-K filings capture material events between quarterly reports, including guidance updates, leadership changes, or significant business developments. AI-powered summaries explain what each filing means for investors, saving time on documents that can otherwise require careful reading to understand.
Whether you're evaluating Vita Coco's ability to maintain market share leadership or assessing whether the stock reflects the company's growth potential, these SEC documents provide the factual foundation for informed analysis.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported a charitable stock donation and his current equity holdings. On December 18, 2025, he donated 666 shares of Vita Coco common stock to a donor-advised fund for charitable purposes, leaving him with 73,847 common shares held directly.
He also reported multiple non-qualified stock options to buy Vita Coco common stock at exercise prices ranging from $10.178 to $33.36, with expiration dates between December 16, 2029 and March 4, 2035. Several of these options are fully vested and currently exercisable, while others vest in equal annual installments beginning on dates from November 27, 2022 through future grant anniversaries, contingent on continued service.
Vita Coco Company, Inc. director Kenneth Sadowsky reported selling 3,900 shares of common stock on 12/17/2025 at a weighted average price of $51.621 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to trade according to a preset schedule.
After this transaction, Sadowsky beneficially owns 612,166 shares of Vita Coco common stock directly. He also holds a fully vested, currently exercisable non-qualified stock option to buy 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on 01/02/2030.
Vita Coco Company, Inc. (COCO) Chief Executive Officer and director Martin Roper reported an indirect charitable transfer of company stock. On 11/25/2025, his spouse donated 20,000 shares of Vita Coco common stock to a donor-advised fund for charitable purposes, recorded as a disposition at a price of $0.0 per share. Following this transaction, Roper reports 41,200 shares held indirectly by his spouse and 281,562 shares held directly, along with additional indirect holdings through three exempt family trusts. He also holds several non-qualified stock options to purchase Vita Coco common stock, including options for 579,670 shares at an exercise price of $10.178 per share that are fully vested and currently exercisable, plus other option grants with exercise prices ranging from $15 to $32.78 and expirations between 2029 and 2035.
Vita Coco Company, Inc. director trade disclosure: A reporting person related to Vita Coco (ticker COCO) sold shares of common stock on 11/24/2025 under a pre-arranged Rule 10b5-1 trading plan. The transactions included sales of 25,381 shares at a weighted average price of $50.294 and 33,862 shares at a weighted average price of $50.271.
Following these sales, the reporting person held 498,341 shares of Vita Coco common stock directly and 602,579 shares indirectly through the Ira Liran 2012 Family Trust. The prices reflect multiple trades within stated ranges, and detailed trade-by-trade pricing is available upon request as noted in the disclosure.
Vita Coco Company, Inc. (COCO)$47.115 per share, with individual trades executed between $46.32 and $47.45. The filing notes these sales were made under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Sadowsky beneficially owns 616,066 Vita Coco common shares directly. He also holds a non-qualified stock option to purchase 27,300 shares at an exercise price of $10.178 per share, which is fully vested and exercisable and expires on 01/02/2030.
The Vita Coco Company, Inc. (COCO) chief sales officer Charles Van Es reported an option exercise and share sale. On 11/17/2025 he exercised 20,000 non-qualified stock options for common stock at an exercise price of $10.178 per share and acquired 20,000 shares. On the same day, he sold 20,000 shares of common stock at $50 per share under a Rule 10b5-1 trading plan. After these transactions, he beneficially owned 84,328 shares of common stock directly, along with multiple option grants that are vested or vest over time through 2035.
Vita Coco Company, Inc. (COCO)11/17/2025, he sold 14,619 shares of common stock at a weighted average price of $50.102 per share and another 26,138 shares at a weighted average price of $50.086 per share, with the latter held indirectly.
After these transactions, Liran beneficially owned 523,722 shares of Vita Coco common stock directly and 636,441 shares indirectly through the Ira Liran 2012 Family Trust. The filing notes that the sales prices reflect weighted averages across multiple trades between $50.00 and $50.47 per share.
Vita Coco Company, Inc. (COCO) Chief Operating Officer Jonathan Burth reported option exercises and share sales of company stock. On 11/17/2025, he exercised 17,666 stock options at an exercise price of $10.178 per share and sold 17,666 common shares in a separate transaction at a weighted average price of $48.684 per share under a Rule 10b5-1 trading plan. The same day, he exercised an additional 20,000 options at $10.178 per share and sold 20,000 shares at a weighted average price of $50.019 per share. Following these transactions, he directly held 76,127 shares of common stock and a significant number of vested and unvested non-qualified stock options with various exercise prices and expiration dates.
Vita Coco Company, Inc. (COCO)5,102 shares of common stock was executed at $44 per share. After this trade, Kirban beneficially owns 127,629 shares directly, 1,479,049 shares indirectly through the Michael Kirban 2010 Trust, and 615,681 shares indirectly through the Michael Kirban Revocable Trust.
Kirban also holds several non-qualified stock options, including 546,000 options with a $10.178 exercise price expiring 12/16/2029 and other grants with exercise prices ranging from $15 to $32.78 and expirations through 03/03/2035. Some options are fully vested and currently exercisable, while others vest in four equal annual installments starting on specified dates.
Vita Coco Company, Inc. (COCO)10,000 shares of common stock at an exercise price of $10.178 per share and then sold 10,000 shares at a weighted average price of $43.7226 per share under a Rule 10b5-1 trading plan. Following these transactions, the reporting person beneficially owned 12,162 shares of common stock directly and held 20,675 stock options, which are fully vested and currently exercisable, with an expiration date of 12/16/2029.
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
